IndraLab
Statements
Sodium(1+) inhibits NLRP3. 16 / 16
|
16
reach
"Sodium Danshensu (SDSS) was found to inhibit the triggering of the NLRP3 inflammasome and reduce chloride efflux by binding to chloride intracellular channel 4 (CLIC4), thereby inhibiting caspase-1 cleavage and GSDMD-N shearing, suppresses the production and release of IL-1β and IL-18, reducing vascular endothelial cell pyroptosis, and alleviating CIRI [13]."
reach
"Conclusions : Sodium butyrate can inhibit the activation of NLRP3 inflammasome and decrease the production of IL-1beta and IL-18 in intestinal mucosa of severe scald mice, which protects the intestinal barrier function by alleviating the alteration of tight junction protein expression and localization."
reach
"Dimethyl fumarate (DMF) and 3-(2-oxo-2-phenylethylidene)-2,3,6,7-tetrahydro-1H-pyrazino-[2,1-a]isoquinolin-4(11bH)-one (compound 1), the Nrf2 activators, were found to ameliorate dextran sulfate sodium (DSS)-induced colitis (an animal model mimicking human IBD) via activating Nrf2 and inhibiting NLRP3 inflammasome [121,122]."